Interferon gamma release assays for latent tuberculosis: What are the sources of variability?

Journal of Clinical Microbiology

Volumn 54, Issue 4, 2016, Pages 845-850

  Banaei, Niaz ^a,b   Gaur, Rajiv L ^a   Pai, Madhukar ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; AUTOMATION; BETWEEN LABORATORY IMPRECISION; BETWEEN OPERATOR IMPRECISION; BETWEEN RUN IMPRECISION; BLOOD SAMPLING; BLOOD VOLUME; DIAGNOSTIC KIT; IMMUNE BOOSTING; IMMUNOLOGY; INCUBATION DELAY; INCUBATION TIME; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LYMPHOCYTE COUNT; MANUFACTURING INDUSTRY; MEDICAL PARAMETERS; PBMC STORAGE; PLASMA SEPARATION DELAY; PLASMA STORAGE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN DECONTAMINATION; STATISTICAL PARAMETERS; T LYMPHOCYTE; TRANSPORTATION TEMPERATURE; TRAUMATIC BLOOD DRAW; TUBE SHAKING; VACCINATION; VARIABILITY; WITHIN RUN IMPRECISION; DIAGNOSTIC TEST; HUMAN; PROCEDURES;

DIAGNOSTIC TESTS, ROUTINE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; REPRODUCIBILITY OF RESULTS;

EID: 84962571451     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02803-15     Document Type: Review

References (35)

1. Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, Metcalfe JZ, Cattamanchi A, Dowdy DW, Dheda K, Banaei N. 2014. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 27:3-20. http://dx.doi.org/10.1128/CMR.00034-13.
2. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, Mahomed H, McShane H, the MVA85A 020 Trial Study Team. 2013. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial. Lancet 381:1021-1028. http://dx.doi.org/10.1016/S0140-6736(13)60177-4.
3. Tagmouti S, Slater M, Benedetti A, Kik SV, Banaei N, Cattamanchi A, Metcalfe J, Dowdy D, van Zyl Smit R, Dendukuri N, Pai M, Denkinger C. 2014. Reproducibility of interferon gamma (IFN-gamma) release assays. A systematic review. Ann Am Thorac Soc 11:1267-1276. http://dx.doi.org/10.1513/AnnalsATS.201405-188OC.
4. Mazurek GH, Whitworth WC, Goodwin DJ. 2012. Affect of blood collection time on Quantiferon-TB Gold In-Tube test variability. Am J Respir Crit Care Med 185:A4735.
5. Gaur RL, Pai M, Banaei N. 2013. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold intube assay. J Clin Microbiol 51:3521-3526. http://dx.doi.org/10.1128/JCM.01627-13.
6. Smith SG, Joosten SA, Verscheure V, Pathan AA, McShane H, Ottenhoff TH, Dockrell HM, Mascart F. 2009. Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One 4:e7972. http://dx.doi.org/10.1371/journal.pone.0007972.
7. Doberne D, Gaur RL, Banaei N. 2011. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J Clin Microbiol 49:3061-3064. http://dx.doi.org/10.1128/JCM.01136-11.
8. Herrera V, Yeh E, Murphy K, Parsonnet J, Banaei N. 2010. Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold intube assay. J Clin Microbiol 48:2672-2676. http://dx.doi.org/10.1128/JCM.00482-10.
9. Yun JW, Chung HS, Koh WJ, Chung DR, Kim YJ, Kang ES. 2014. Significant reduction in rate of indeterminate results of the Quanti-FERON-TB Gold In-Tube test by shortening incubation delay. J Clin Microbiol 52:90-94. http://dx.doi.org/10.1128/JCM.01547-13.
10. Jarvis J, Gao Y, de Graaf H, Hughes S, Allan RN, Williams A, Marshall B, Elkington P, Faust SN, Tebruegge M. 2015. Environmental temperature impacts on the performance of QuantiFERON-TB Gold In-Tube assays. J Infect 71:276-280. http://dx.doi.org/10.1016/j.jinf.2015.04.004.
11. Beffa P, Zellweger A, Janssens JP, Wrighton-Smith P, Zellweger JP. 2008. Indeterminate test results of T-SPOT.TB performed under routine field conditions. Eur Respir J 31:842-846. http://dx.doi.org/10.1183/09031936.00117207.
12. Wang SH, Stew SS, Cyktor J, Carruthers B, Turner J, Restrepo BI. 2012. Validation of increased blood storage times with the T-SPOT.TB assay with T-Cell Xtend reagent in individuals with different tuberculosis risk factors. J Clin Microbiol 50:2469-2471. http://dx.doi.org/10.1128/JCM.00674-12.
13. Bouwman JJ, Thijsen SF, Bossink AW. 2012. Improving the timeframe between blood collection and interferon gamma release assay using T-Cell Xtend. J Infect 64:197-203. http://dx.doi.org/10.1016/j.jinf.2011.10.017.
14. Lenders LM, Meldau R, van Zyl-Smit RN, Woodburne V, Maredza A, Cashmore TJ, Semple PL, Badri M, Zumla A, Dheda K. 2010. Comparison of same day versus delayed enumeration of TB-specific T cell responses. J Infect 60:344-350. http://dx.doi.org/10.1016/j.jinf.2010.01.012.
15. King TC, Upfal M, Gottlieb A, Adamo P, Bernacki E, Kadlecek CP, Jones JG, Humphrey-Carothers F, Rielly AF, Drewry P, Murray K, DeWitt M, Matsubara J, O'Dea L, Balser J, Wrighton-Smith P. 2015. T-SPOT.TB interferon-gamma release assay performance in healthcare worker screening at nineteen U.S. hospitals. Am J Respir Crit Care Med 192:367-373. http://dx.doi.org/10.1164/rccm.201501-0199OC.
16. Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, Kruger C, Du Plessis N, Kidd M, Beyers N, Walzl G, Hesseling AC. 2009. Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol 16:1170-1175. http://dx.doi.org/10.1128/CVI.00168-09.
17. Wild D. 2005. The immunoassay handbook. Elsevier, Amsterdam, The Netherlands.
18. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA. 2013. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 187:206-211. http://dx.doi.org/10.1164/rccm.201203-0430OC.
19. Whitworth WC, Hamilton LR, Goodwin DJ, Barrera C, West KB, Racster L, Daniels LJ, Chuke SO, Campbell BH, Bohanon J, Jaffar AT, Drane W, Maserang D, Mazurek GH. 2012. Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests. PLoS One 7:e43790. http://dx.doi.org/10.1371/journal.pone.0043790.
20. Tuuminen T, Tavast E, Vaisanen R, Himberg JJ, Seppala I. 2010. Assessment of imprecision in gamma interferon release assays for the de-tection of exposure to Mycobacterium tuberculosis. Clin Vaccine Immunol 17:596-601. http://dx.doi.org/10.1128/CVI.00320-09.
21. Whitworth WC, Goodwin DJ, Racster L, West KB, Chuke SO, Daniels LJ, Campbell BH, Bohanon J, Jaffar AT, Drane W, Sjoberg PA, Mazurek GH. 2014. Variability of the QuantiFERON-TB gold in-tube test using automated and manual methods. PLoS One 9:e86721. http://dx.doi.org/10.1371/journal.pone.0086721.
22. Franken WP, Thijsen S, Wolterbeek R, Bouwman JJ, el Bannoudi H, Kik SV, van Dissel JT, Arend SM. 2009. Variation in T-SPOT.TB spot interpretation between independent observers from different laboratories. Clin Vaccine Immunol 16:1439-1442. http://dx.doi.org/10.1128/CVI.00456-08.
23. van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, Dheda K. 2009. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.AmJ Respir Crit Care Med 180:49-58. http://dx.doi.org/10.1164/rccm.200811-1704OC.
24. Slater M, Parsonnet J, Banaei N. 2012. Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay. J Clin Microbiol 50:3105-3107. http://dx.doi.org/10.1128/JCM.00730-12.
25. Slater M, Dubose A, Banaei N. 2014. False-positive quantiferon results at a large healthcare institution. Clin Infect Dis 58:1641-1642. http://dx.doi.org/10.1093/cid/ciu139.
26. Couturier MR, Myatt R, Dorn D, Yang DT, Pitstick N. 2014. Defective antigen tubes generate false-positive QuantiFERON tuberculosis test results. Clin Infect Dis 59:1649-1650. http://dx.doi.org/10.1093/cid/ciu644.
27. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. 2009. Within-subject variability of interferon-assay results for tuberculosis and boosting effect of tuberculin skin testing: A systematic review. PLoS One 4:e8517. http://dx.doi.org/10.1371/journal.pone.0008517.
28. Naseer A, Naqvi S, Kampmann B. 2007. Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing. Eur Respir J 29:1282-1283. http://dx.doi.org/10.1183/09031936.00017807.
29. Baker CA, Thomas W, Stauffer WM, Peterson PK, Tsukayama DT. 2009. Serial testing of refugees for latent tuberculosis using the Quanti-FERON-gold in-tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg 80:628-633.
30. Igari H, Watanabe A, Sato T. 2007. Booster phenomenon of Quanti-FERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis 11:788-791.
31. Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J. 2008. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 15:425-432. http://dx.doi.org/10.1128/CVI.00398-07.
32. Mogensen TH. 2009. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22:240-273. http://dx.doi.org/10.1128/CMR.00046-08.
33. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. 2010. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 16:228-231. http://dx.doi.org/10.1038/nm.2087.
34. Gaur RL, Suhosk MM, Banaei N. 2012. In vitro immunomodulation of a whole blood IFN-release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS One 7:e48027. http://dx.doi.org/10.1371/journal.pone.0048027.
35. Gaur RL, Banaei N. 2014. Inoculation of QuantiFERON-TB tubes with skin microbiota causes false-positive results. Am J Respir Crit Care Med 190:834-837. http://dx.doi.org/10.1164/rccm.201406-1041LE.